Molecular Partners AG, which is commercializing a protein scaffold technology, raised CHF46 million (US$44.2 million) in a Series B financing round led by Essex Woodlands Health Ventures, taking its total investment raised in the past two and a half years to CHF64.5 million.(BioWorld International)